Clinical trial
Study of Vioxx and Radiation Therapy for Brainstem Glioma
NCT00038389 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00038389 |
|---|---|
| Title | Study of Vioxx and Radiation Therapy for Brainstem Glioma |
| Official title | Phase I Study of Vioxx and Radiation Therapy for Brainstem Glioma |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Glioma, Brain Neoplasms |
| Intervention type | Drug |
| Interventions | Vioxx |
| Enrollment | 8 |
| Start date | Oct 1, 2001 |
| Primary completion | Oct 1, 2004 |
| Completion | Jan 1, 2005 |
| First posted | May 31, 2002 |
| Last update posted | Nov 1, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: